NCT02150707View on ClinicalTrials.gov

The Differential Effects of Diabetes Therapy on Inflammation

CompletedOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Diabetic NephropathyType 2 Diabetes
Interventions
DRUG

Dipeptidyl-Peptidase IV Inhibitors

Dipeptidyl-Peptidase IV Inhibitors to treat hyperglycaemia

DRUG

Glucagon-Like Peptide 1

Glucagon-Like Peptide 1 to treat hyperglycaemia

Trial Locations (1)

Dublin 7

Mater Misericordiae University Hospital, Dublin

All Listed Sponsors
collaborator

Irish Endocrine Society

OTHER

collaborator

Royal College of Physicians

OTHER

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Eli Lilly and Company

INDUSTRY

lead

University College Dublin

OTHER

NCT02150707 - The Differential Effects of Diabetes Therapy on Inflammation | Biotech Hunter | Biotech Hunter